These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9125193)

  • 1. Changes of p53 in the brains of patients with Alzheimer's disease.
    Kitamura Y; Shimohama S; Kamoshima W; Matsuoka Y; Nomura Y; Taniguchi T
    Biochem Biophys Res Commun; 1997 Mar; 232(2):418-21. PubMed ID: 9125193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
    Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
    Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53- and CD95-associated apoptosis in neurodegenerative diseases.
    de la Monte SM; Sohn YK; Ganju N; Wands JR
    Lab Invest; 1998 Apr; 78(4):401-11. PubMed ID: 9564885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for apoptotic cell death in Alzheimer's disease.
    Smale G; Nichols NR; Brady DR; Finch CE; Horton WE
    Exp Neurol; 1995 Jun; 133(2):225-30. PubMed ID: 7544290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally altered p53: a putative peripheral marker for Alzheimer's disease.
    Uberti D; Lanni C; Racchi M; Govoni S; Memo M
    Neurodegener Dis; 2008; 5(3-4):209-11. PubMed ID: 18322392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
    von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
    Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDRG2: a novel Alzheimer's disease associated protein.
    Mitchelmore C; Büchmann-Møller S; Rask L; West MJ; Troncoso JC; Jensen NA
    Neurobiol Dis; 2004 Jun; 16(1):48-58. PubMed ID: 15207261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally altered p53: a novel Alzheimer's disease marker?
    Lanni C; Racchi M; Mazzini G; Ranzenigo A; Polotti R; Sinforiani E; Olivari L; Barcikowska M; Styczynska M; Kuznicki J; Szybinska A; Govoni S; Memo M; Uberti D
    Mol Psychiatry; 2008 Jun; 13(6):641-7. PubMed ID: 17684496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
    Muma NA; Mariyappa R; Williams K; Lee JM
    Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients.
    Zhou X; Jia J
    Neurosci Lett; 2010 Jan; 468(3):320-5. PubMed ID: 19914341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
    Spiechowicz M; Bernstein HG; Dobrowolny H; Leśniak W; Mawrin C; Bogerts B; Kuźnicki J; Filipek A
    Neurochem Int; 2006 Oct; 49(5):487-93. PubMed ID: 16698122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
    Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
    Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
    Kumar U; Patel SC
    Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.
    Kawamata T; Tooyama I; Yamada T; Walker DG; McGeer PL
    Am J Pathol; 1993 May; 142(5):1574-85. PubMed ID: 8494052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of neuronal death by promoting degradation of intracellular amyloid beta-protein].
    Ohyagi Y; Miyoshi K; Ma L; Motomura K; Kira J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):57-62. PubMed ID: 17515111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
    Kawamoto Y; Akiguchi I; Jarius C; Budka H
    Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leakage and neuronal uptake of serum protein in aged and Alzheimer brains. A postmortem phenomenon with antemortem etiology.
    Mori S; Sternberger NH; Herman MM; Sternberger LA
    Lab Invest; 1991 Mar; 64(3):345-51. PubMed ID: 2002653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.